84
Participants
Start Date
November 30, 2010
Primary Completion Date
April 30, 2013
Study Completion Date
December 31, 2013
EN3348
Induction: 6 weekly instillations. Maintenance: Monthly instillations to Month 12
Mitomycin C
Induction: 6 weekly instillations. Maintenance: Monthly instillations to Month 12
Universitair Medisch Centrum St Radboud, Department of Urology, Nijmegen
Columbia University Medical Center, New York
Montefiore Medical Center, The Bronx
Accumed Research Associates, Garden City
The Capital Region Medical Research Foundation, Inc., Albany
Premier Medical Group of the Hudson Valley, Poughkeepsie
Triangle Urological Group, Pittsburgh
University of Pittsburgh, Pittsburgh
Ilumina Clinical Associates, Indiana
Mount Nittany Physician Group, State College
Urologic Consultants of SE PA, Bala-Cynwyd
Urology Health Specialists, LLC, Bryn Mawr
Myron I. Murdock, MD, LLC, Greenbelt
Chesapeake Urology Research Associates, Glen Burnie
University of Maryland, Baltimore
Chesapeake Urology Research Associates, Towson
Chesapeake Urology Research Associates, Baltimore
Corbin Clinical Resources, Cumberland
Virginia Urology, Richmond
Carolina Urologic Research Center, Myrtle Beach
Urological Research Network, Hialeah
Florida Urological Associates, PA, Coral Springs
Urology Health Team, PLLC, Ocala
Advanced Research Institute, Inc., Trinity
Vanderbilt University Medical Center, Nashville
Columbus Urology, Columbus
Unison Clinical Research, Toledo
Signal Point Clinical Research Center, LLC, Middletown
TriState Urologic Services PSC, Inc., Cincinnati
Northeast Indiana Research, LLC, Fort Wayne
Deaconess Clinic, Inc., Evansville
Michigan Institute of Urology, Troy
Northwestern Medicine, Chicago
University of Chicago, Chicago
Kansas City Urology Care, P.A., Overland Park
Parkhurst Research Organization, LLC, Bethany
GUT (Society of Urologic Innovative Therapies), GbR, Kirchheim unter Teck
Urology Clinics of North Texas, PA, Dallas
Urology Associates of North Texas, Arlington
Urology Associates of South Texas, McAllen
Urology Associates, Englewood
The Urology Center of Colorado, Denver
Genitourinary Surgical Consultants, PC, Denver
BCG Oncology, PC, Phoenix
Arizona Urologic Specialists, Tucson
American Institute of Research, Los Angeles
Urology Specialists of Southern California - Torrance, Torrance
West Coast Clinical Research, Tarzana
Urology Specialist of Southern California - Encino, Encino
Urology Specialists of Southern California - Burbank, Burbank
San Diego Clinical Trials, San Diego
Alaska Clinical Research Center, LLC, Anchorage
University of Connecticut Health Center, Farmington
Grove Hill Medical Center, New Britain
Bay State Urologists, Watertown
Delaware Valley Urology, LLC Burlington, Mount Laurel
Delaware Valley Urology, Voorhees Township
Pharma Resource, East Providence
Southern Interior Medical Research, Inc., Kelowna
Pacific Urologic Research, Victoria
London Health Sciences Centre, London
Mor Urology Inc., Newmarket
Office of Dr. Bernard Goldfarb, North Bay
The Fe/Male Health Centres, Oakville
Sunnybrook Health Sciences Centre, Toronto
Princess Margaret Hospital - University Health Network, Toronto
Centre Hospitalier Universitaire de Quebec- L'Hotel-Dieu de Quebec, Québec
Uniwersyteckie Centrum Kliniczne, Gdansk
Oddział Urologii, Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie [Department of Urology, Independent Public Teaching Hospital #4 in Lublin], Lublin
Maria Sklodowska-Curie Institute of Oncology, Warsaw
Wojewódzki Szpital Specjalistyczny we Wrocławiu, Wroclaw
Nottingham Urology Centre, NHS Trust, Nottingham
Lead Sponsor
Bioniche Life Sciences Inc.
INDUSTRY